Security key
71678J100
- Security type / class
- Equity / COM
- Total 13F shares
- 672,970
- Total 13F value
- $558,000
- Share change
- -160,540
- Put/Call ratio
- 108%
- SEC-reported price per share
- $0.83
- Number of holders
- 12
- Value change
- -$369,577
- Number of buys
- 7
- Number of sells
- 7
Open additional details 1 more signal available
Report period
Q2 2022
Institutions
12
Top holders
10
PTPI full security history
Ownership snapshot
Full 13F holder table
Petros Pharmaceuticals, Inc. SEC filings
Petros Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of PTPI - PETROS PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
John D. Shulman
Disclosed value leader
John D. Shulman
Comparable rows
0/15
Latest evidence
31 Mar 2022
3/4/5
13F
Highest disclosed value: $19,563,156
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
John D. Shulman has the largest disclosed position value at $19.56M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens John D. Shulman's linked filing trail.
Disclosed position value
Top 5
John D. Shulman
$19.56M
BlackRock Finance, Inc.
$300K
MARSHALL WACE, LLP
$205K
VANGUARD GROUP INC
$178K
TWO SIGMA INVESTMENTS, LP
$162K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| John D. Shulman |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$19,563,156
5,812,873 shares
mixed-class rows
|
— | 22 Dec 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$300,000
191,715 shares
|
— | 31 Mar 2022 |
| MARSHALL WACE, LLP |
13F
Company
|
—
denominator unverified
|
$205,000
131,196 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$178,000
113,823 shares
|
— | 31 Mar 2022 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
—
denominator unverified
|
$162,000
104,120 shares
|
— | 31 Mar 2022 |
| TWO SIGMA ADVISERS, LP |
13F
Company
|
—
denominator unverified
|
$115,000
73,800 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
12
Shares
672,970
Rows available
12
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
15
Q2 2022 holders
12
Holder diff
-3
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|